Impact of pituitary adenoma histological subtype on remission and disease control in acromegaly
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgag174 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Alexandra Monnot und 6 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron 69677, France. Hauptthemen laut MEDLINE: Acromegaly, Adenoma, Growth Hormone-Secreting Pituitary Adenoma, Pituitary Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 55 Literaturangaben. Gefördert von: Bibliothèque Scientifique de l'Internat de Lyon and the Hospices Civils de Lyon, Bibliothèque Scientifique de l’Internat de Lyon and the Hospices Civils de Lyon.
Abstract (Originalsprache)
Introduction
Acromegaly results from different histological subtypes of pituitary adenomas, mainly pure GH-secreting adenomas (densely or sparsely granulated) and GH-PRL adenomas. Data on the impact of histological subtype on surgical outcomes in acromegaly remain limited.
Objectives
This study aimed to assess the impact of pituitary adenoma histological subtype on acromegaly remission at 3 months and last follow-up, as well as on disease control.
Methods
We conducted a retrospective, single-center study of 128 patients who underwent surgery for GH or GH-PRL adenomas, without prior medical therapy, between 2012 and 2022.
Results
Among the adenomas, 61% were pure GH (39% DG, 22% SG) and 39% were GH-PRL. Compared with DG adenomas, SG adenomas were diagnosed at a younger age (P = .006), were larger (P = .022), expressed more SST5 (P = .032) and less SST2 (P < .001). GH-PRL adenomas were more frequently p53-positive (P = .024), had a higher mitotic count (P = .017) than DG adenomas and expressed more SST2 than SG adenomas (P < .001). The remission rates for DG, GH-PRL and SG adenomas were not significantly different at 3 months (60%, 58% and 43%, P = .337), or at last follow-up (80%, 74% and 57%, P = .091), nor was disease control at last follow-up (94%, 96% and 82%, P = .115) after 42 months.
Conclusion
Histological subtype was not significantly associated with remission or control of acromegaly. Although a trend toward lower remission rates was observed in SG adenomas, its clinical impact appears limited.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Endocrinology Department, Reference Center for Rare Pituitary Diseases HYPO, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron 69677, France.
- Inserm U1052, CNRS UMR5286, Claude Bernard Lyon 1 University, Cancer Research Center of Lyon, Lyon 69008, France.
- Endocrinology Department, C.I. Parhon National Institute of Endocrinology, Bucharest 011863, Romania.
- Pathology Department, Reference Center for Rare Pituitary Diseases HYPO, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron 69677, France.
- Neurosurgery Department, Reference Center for Rare Pituitary Diseases HYPO, Groupement Hospitalier Est, Hospices Civils de Lyon, Bron 69677, France.
ORCID-Profile: Alexandra Monnot, Mirela-Diana Ilie, Camille Sergeant, Alexandre Vasiljevic, Emmanuel Jouanneau, Gérald Raverot
Förderung
- Bibliothèque Scientifique de l'Internat de Lyon and the Hospices Civils de Lyon
- Bibliothèque Scientifique de l’Internat de Lyon and the Hospices Civils de Lyon
Zitieren
APA
Monnot, A., Ilie, M. D., Sergeant, C., Vasiljevic, A., Zaghdoud, S., Jouanneau, E., & Raverot, G. (2026). Impact of pituitary adenoma histological subtype on remission and disease control in acromegaly. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag174
Vancouver
Monnot A, Ilie MD, Sergeant C, Vasiljevic A, Zaghdoud S, Jouanneau E, et al. Impact of pituitary adenoma histological subtype on remission and disease control in acromegaly. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag174
BibTeX
@article{Monnot2026,
author = {Monnot, Alexandra and Ilie, Mirela-Diana and Sergeant, Camille and Vasiljevic, Alexandre and Zaghdoud, Sihem and Jouanneau, Emmanuel and Raverot, Gérald},
title = {Impact of pituitary adenoma histological subtype on remission and disease control in acromegaly},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgag174}
}
EUVIMED